• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肥厚型心肌病体格检查的临床意义。

Clinical Significance of Physical Examination for Hypertrophic Cardiomyopathy.

机构信息

Department of Cardiology, Matsushita Memorial Hospital.

Department of Cardiovascular Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine.

出版信息

Circ J. 2023 Jul 25;87(8):1068-1074. doi: 10.1253/circj.CJ-23-0131. Epub 2023 Jun 7.

DOI:10.1253/circj.CJ-23-0131
PMID:37286487
Abstract

BACKGROUND

Patients with hypertrophic cardiomyopathy (HCM) show various physical findings, but their clinical significance has not been systematically evaluated.

METHODS AND RESULTS

This study evaluated 105 consecutive patients with HCM who had undergone phonocardiography and external pulse recording. Physical examinations included a visible jugular a-wave (Jug-a), audible 4th sound (S4), and double or sustained apex beat. The primary outcome was a composite of all-cause death and hospitalization for cardiovascular disease. A total of 104 non-HCM subjects served as controls. The prevalence of visible Jug-a in the seated or supine position, audible S4, and a sustained or double apex beat in patients with HCM were 10%, 71%, 70%, 42%, and 27%, respectively, all of which were significantly higher than in the controls (0%, 20%, 11%, 17%, and 2%; P<0.001 for all comparisons). The combination of visible Jug-a in the supine position and audible S4 yielded a specificity of 94% and sensitivity of 57%. During a follow-up period of 6.6 years, 6 patients died and 10 were hospitalized. The absence of audible S4 was a predictor of cardiovascular events (hazard ratio, 3.91; 95% confidence interval, 1.41 to 10.8; P=0.005).

CONCLUSIONS

Detection of these findings has clinical importance in the diagnosis and risk stratification of HCM prior to the use of advanced imaging techniques.

摘要

背景

肥厚型心肌病(HCM)患者表现出各种体格检查结果,但这些结果的临床意义尚未得到系统评估。

方法和结果

本研究评估了 105 例连续接受心音图和外部脉搏记录的 HCM 患者。体格检查包括可见颈静脉 a 波(Jug-a)、可闻 4 心音(S4)、双重或持续心尖搏动。主要终点是全因死亡和心血管疾病住院的复合终点。104 例非 HCM 患者作为对照。HCM 患者中仰卧或坐姿可见 Jug-a、可闻 S4、持续或双重心尖搏动的发生率分别为 10%、71%、70%、42%和 27%,均显著高于对照组(0%、20%、11%、17%和 2%;所有比较 P<0.001)。仰卧位可见 Jug-a 与可闻 S4 联合检测的特异性为 94%,敏感性为 57%。在 6.6 年的随访期间,有 6 例患者死亡,10 例患者住院。无可闻 S4 是心血管事件的预测因子(风险比,3.91;95%置信区间,1.41 至 10.8;P=0.005)。

结论

在使用先进的成像技术之前,这些发现对于 HCM 的诊断和风险分层具有临床重要意义。

相似文献

1
Clinical Significance of Physical Examination for Hypertrophic Cardiomyopathy.肥厚型心肌病体格检查的临床意义。
Circ J. 2023 Jul 25;87(8):1068-1074. doi: 10.1253/circj.CJ-23-0131. Epub 2023 Jun 7.
2
Third and Fourth Heart Sounds and Myocardial Fibrosis in Hypertrophic Cardiomyopathy.第三心音和第四心音与肥厚型心肌病中的心肌纤维化。
Circ J. 2018 Jan 25;82(2):509-516. doi: 10.1253/circj.CJ-17-0650. Epub 2017 Sep 16.
3
Absent fourth heart sound as a marker of adverse events in hypertrophic cardiomyopathy with sinus rhythm.第四心音缺失作为窦性节律肥厚型心肌病不良事件的标志物。
Ann Noninvasive Electrocardiol. 2022 May;27(3):e12932. doi: 10.1111/anec.12932. Epub 2022 Feb 11.
4
Simple Phonocardiography with the Ankle-Brachial Index Measurement System as a Tool for Detecting Fourth Heart Sounds of Hypertrophic Cardiomyopathy.应用踝臂指数测量系统进行简易心音听诊检测肥厚型心肌病第四心音
Int Heart J. 2022 Jul 30;63(4):729-733. doi: 10.1536/ihj.22-025. Epub 2022 Jul 14.
5
Prevalence, characteristics, and natural history of apical phenotype in a large cohort of patients with hypertrophic cardiomyopathy.一大群肥厚型心肌病患者心尖表型的患病率、特征及自然病史。
Hellenic J Cardiol. 2023 Sep-Oct;73:8-15. doi: 10.1016/j.hjc.2023.02.004. Epub 2023 Feb 11.
6
The usefulness of sST2 and galectin-3 as novel biomarkers for better risk stratification in hypertrophic cardiomyopathy.可溶性ST2和半乳糖凝集素-3作为肥厚型心肌病中用于更好风险分层的新型生物标志物的效用。
Kardiol Pol. 2017;75(10):997-1004. doi: 10.5603/KP.a2017.0118. Epub 2017 Jun 14.
7
Clinical Outcomes in Patients With Nonobstructive, Labile, and Obstructive Hypertrophic Cardiomyopathy.非梗阻性、易变型和梗阻性肥厚型心肌病患者的临床转归。
J Am Heart Assoc. 2018 Feb 25;7(5):e006657. doi: 10.1161/JAHA.117.006657.
8
Relationship Between Genotype Status and Clinical Outcome in Hypertrophic Cardiomyopathy.肥厚型心肌病基因型与临床结局的关系。
J Am Heart Assoc. 2024 May 21;13(10):e033565. doi: 10.1161/JAHA.123.033565. Epub 2024 May 17.
9
Significance of high-sensitivity cardiac troponin T in hypertrophic cardiomyopathy.高敏心肌肌钙蛋白 T 在肥厚型心肌病中的意义。
J Am Coll Cardiol. 2013 Oct 1;62(14):1252-1259. doi: 10.1016/j.jacc.2013.03.055. Epub 2013 Apr 23.
10
Machine Learning in Hypertrophic Cardiomyopathy: Nonlinear Model From Clinical and CMR Features Predicting Cardiovascular Events.机器学习在肥厚型心肌病中的应用:基于临床和 CMR 特征的非线性模型预测心血管事件。
JACC Cardiovasc Imaging. 2024 Aug;17(8):880-893. doi: 10.1016/j.jcmg.2024.04.013. Epub 2024 Jul 10.

引用本文的文献

1
Midventricular Obstruction With Diastolic Paradoxic Jet Flow in Transthyretin Cardiac Amyloidosis: A Case Report.转甲状腺素蛋白心脏淀粉样变性伴舒张期矛盾射流的心室中部梗阻:一例报告
Cureus. 2025 Jan 7;17(1):e77097. doi: 10.7759/cureus.77097. eCollection 2025 Jan.
2
Physical Examination as a Clue to Transthyretin Cardiac Amyloidosis: A Case Report.体格检查作为转甲状腺素蛋白心脏淀粉样变的线索:一例报告
Cureus. 2023 Aug 3;15(8):e42925. doi: 10.7759/cureus.42925. eCollection 2023 Aug.